Literature DB >> 12773680

Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.

Young Cheol Yoon1, Kyung Soo Lee, Young Mog Shim, Byung-Tae Kim, Kwhanmien Kim, Tae Sung Kim.   

Abstract

PURPOSE: To prospectively compare the accuracy of fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and computed tomography (CT) for detection of primary tumor and metastasis to individual lymph node groups and for nodal staging.
MATERIALS AND METHODS: From February 2000 to July 2001, 81 patients with squamous cell carcinoma of the esophagus (78 men and three women; age range, 31-90 years; mean age, 63 years) underwent CT and FDG PET before esophagectomy and lymph node dissection. During surgery, all visible and palpable lymph nodes in the surgical fields were removed. The accuracies of CT and FDG PET for depiction of metastasis to lymph nodes were compared.
RESULTS: For depiction of malignant nodal groups in each lymph node group, the sensitivity, specificity, and accuracy, respectively, of CT were 11% (11 of 96 nodal groups), 95% (553 of 581), and 83% (564 of 677), whereas those of FDG PET were 30% (29 of 96), 90% (525 of 581), and 82% (554 of 677) (P values: < .001, .009, and .382, respectively). Twenty-eight false-positive interpretations were rendered at CT in evaluations of 11 mediastinal, four hilar, and 13 abdominal nodal groups, and 56 false-positive interpretations were rendered at FDG PET in evaluations of 23 mediastinal, 32 hilar, and one abdominal nodal group.
CONCLUSION: FDG PET is more sensitive than CT for depicting nodal metastases in patients with squamous cell carcinoma of the esophagus. FDG PET is slightly less specific than CT for depicting metastases, but the difference in specificity between the two modalities is statistically significant. Both FDG PET and CT have low sensitivity for depicting nodal metastasis. The relatively low specificity of FDG PET for depiction of nodal metastasis compared with that of CT is caused mainly by a high rate of false-positive hilar node interpretations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773680     DOI: 10.1148/radiol.2281020423

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  55 in total

1.  PET: other thoracic malignancies.

Authors:  Leslie E Quint
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

2.  Quantitative measurement of contrast enhancement of esophageal squamous cell carcinoma on clinical MDCT.

Authors:  Rui Li; Tian-Wu Chen; Li-Ying Wang; Li Zhou; Hang Li; Xiao-Li Chen; Chun-Ping Li; Xiao-Ming Zhang; Ru-Hui Xiao
Journal:  World J Radiol       Date:  2012-04-28

3.  Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma.

Authors:  S H Kim; K-N Lee; E J Kang; D W Kim; S H Hong
Journal:  Br J Radiol       Date:  2011-02-08       Impact factor: 3.039

4.  Preoperative lymph node status on computed tomography influences the survival of pT1b, T2 and T3 esophageal squamous cell carcinoma.

Authors:  Kotaro Sugawara; Hiroharu Yamashita; Yukari Uemura; Koichi Yagi; Masato Nishida; Susumu Aikou; Sachiyo Nomura; Yasuyuki Seto
Journal:  Surg Today       Date:  2018-11-23       Impact factor: 2.549

5.  Diagnostic sensitivity of ¹⁸fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients.

Authors:  Norio Kondo; Mamoru Tsukuda; Goshi Nishimura
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-09       Impact factor: 2.503

6.  Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer.

Authors:  Ryuichi Karashima; Masayuki Watanabe; Yu Imamura; Satoshi Ida; Yoshifumi Baba; Shiro Iwagami; Yuji Miyamoto; Yasuo Sakamoto; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2014-06-28       Impact factor: 2.549

7.  Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus.

Authors:  Abhinav Dewan; S K Sharma; A K Dewan; Ruparna Khurana; Manoj Gupta; Anjali Pahuja; Himanshu Srivastava; Rupal Sinha
Journal:  J Gastrointest Cancer       Date:  2017-03

8.  Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.

Authors:  Tatsuya Tanaka; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Takeyasu Katada; Midori Shiozaki; Yasuhiro Naganawa; Yoshitaka Fujii; Hiromitsu Takeyama
Journal:  J Exp Clin Cancer Res       Date:  2010-06-28

9.  Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with ¹⁸F-fluorodeoxyglucose positron emission tomography-positive lymph nodes.

Authors:  Takushi Yasuda; Masahiko Yano; Hiroshi Miyata; Makoto Yamasaki; Ichiro Higuchi; Shuji Takiguchi; Yoshiyuki Fujiwara; Yuichiro Doki
Journal:  Surg Today       Date:  2014-06-27       Impact factor: 2.549

10.  Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.

Authors:  Seong Yong Park; Dae Joon Kim; Hee Suk Jung; Mi Jin Yun; Jeong Won Lee; Cheol Keun Park
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.